Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Mouse , Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Highly purified (>98% pure) recombinant human endothelial IL-8 (77 amino acid residues).|
|Storage buffer||PBS, pH 7.2|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Immunohistochemistry (IHC)||Assay Dependent|
|Neutralization (Neu)||Assay Dependent|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (Paraffin) (IHC (P))||See 3 publications below|
|Immunohistochemistry (Frozen) (IHC (F))||See 1 publications below|
|Immunohistochemistry (Paraffin, Frozen) (IHC (P, F))||See 3 publications below|
|ELISA (ELISA)||See 1 publications below|
|Immunohistochemistry (IHC)||See 1 publications below|
Interleukin 8 is a pro-inflammatory factor which belongs to the CXC subfamily of chemokinesk, and which are bound by the cell surface receptors IL-8RA and IL-8RB. IL-8 functions as a chemoattractant and is a potent angiogenic factor. The expression and secretion of IL-8 can be induced by diverse inflammatory stimuli in many cells, including macrophages and endothelial cells. In endothelial cells, IL-8 is present in storage vesicles called Weibel-Palade bodies.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature.
AHC0881 was used in immunohistochemistry - paraffin section to validate the expression of a urine-based bladder cancer associated diagnostic signature
|Zhang G,Gomes-Giacoia E,Dai Y,Lawton A,Miyake M,Furuya H,Goodison S,Rosser CJ||Diagnostic pathology (9:null)||2015|
The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma.
AHC0881 was used in immunohistochemistry - paraffin section and western blot to study the expression and role of CXCR2 and SOCS3 in renal cell carcinoma aggresiveness and metastasis
|Stofas A,Levidou G,Piperi C,Adamopoulos C,Dalagiorgou G,Bamias A,Karadimou A,Lainakis GA,Papadoukakis S,Stravodimos K,Dimopoulos MA,Patsouris E,Gakiopoulou H,Korkolopoulou P||BMC cancer (14:null)||2014|
Interleukin-8, a promising predictor for prognosis of pancreatic cancer.
AHC0881 was used in immunohistochemistry - paraffin section to assess IL-8 as a biomarker for prognosis of pancreatic cancer.
|Chen Y,Shi M,Yu GZ,Qin XR,Jin G,Chen P,Zhu MH||World journal of gastroenterology (18:1123)||2012|
Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
AHC0881 was used in immunohistochemistry - frozen section to investigate the cause of follicular occlusion.
|Emelianov VU,Bechara FG,Gläser R,Langan EA,Taungjaruwinai WM,Schröder JM,Meyer KC,Paus R||The British journal of dermatology (166:1023)||2012|
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
||Shahzad MM,Arevalo JM,Armaiz-Pena GN,Lu C,Stone RL,Moreno-Smith M,Nishimura M,Lee JW,Jennings NB,Bottsford-Miller J,Vivas-Mejia P,Lutgendorf SK,Lopez-Berestein G,Bar-Eli M,Cole SW,Sood AK||The Journal of biological chemistry (285:35462)||2010|
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer.
||Kamat AA,Merritt WM,Coffey D,Lin YG,Patel PR,Broaddus R,Nugent E,Han LY,Landen CN,Spannuth WA,Lu C,Coleman RL,Gershenson DM,Sood AK||Clinical cancer research : an official journal of the American Association for Cancer Research (13:7487)||2007|
Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.
||Kim SJ,Uehara H,Yazici S,He J,Langley RR,Mathew P,Fan D,Fidler IJ||Cancer research (65:3707)||2005|
Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.
||Edwards RJ,Taylor GW,Ferguson M,Murray S,Rendell N,Wrigley A,Bai Z,Boyle J,Finney SJ,Jones A,Russell HH,Turner C,Cohen J,Faulkner L,Sriskandan S||The Journal of infectious diseases (192:783)||2005|
Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.
||Huang J,Yao JL,Zhang L,Bourne PA,Quinn AM,di Sant'Agnese PA,Reeder JE||The American journal of pathology (166:1807)||2005|
NAP-1, GCP1, LECT, MONAP, NAF, LYNAP, NAP1, GCP-1, CXCL8, MDNCF, LUCT
T-cell chemotactic factor, alveolar macrophage chemotactic factor I, beta endothelial cell-derived neutrophil activating peptide, beta-thromboglobulin-like protein, chemokine (C-X-C motif) ligand 8, emoctakin, granulocyte chemotactic protein 1, interleukin-8, lung giant cell carcinoma-derived chemotactic protein, lymphocyte derived neutrophil activating peptide, monocyte-derived neutrophil chemotactic factor, monocyte-derived neutrophil-activating peptide, neutrophil-activating peptide 1, small inducible cytokine subfamily B, member 8, tumor necrosis factor-induced gene 1, Interleukin-8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1